Radicality of proximal gastrectomy – a rewiev

Česká verzia

Authors: P. Lochman; J. Páral
Authors place of work: Katedra vojenské chirurgie, Fakulta vojenského zdravotnictví Univerzity obrany, Hradec Králové ; Katedra vojenské chirurgie, Fakulta vojenského zdravotnictví Univerzity obrany, Brno
Published in the journal: Rozhl. Chir., 2018, roč. 97, č. 8, s. 360-367.
Category: Souhrnné sdělení

Summary

Although the incidence of gastric cancer is decreasing worldwide, the number of esophagogastric junction and upper-third gastric carcinomas is gradually growing. This is due to an increasing incidence of reflux esophagitis with Barrett’s metaplasia and successful eradication of Helicobacter pylori infection. Treatment options for these tumors include proximal gastrectomy. The only currently accepted indication for proximal gastrectomy is early gastric cancer with no preoperative evidence of lymph node involvement. In Western countries, however, advanced gastric cancers are treated using this method as well in spite of the above recommendation. Oncological radicality is a widely discussed issue. If R0 resection and at least D1+ lymphadenectomy are achieved in proximal gastrectomy, the overall survival is comparable with total gastrectomy in early gastric cancers. Recurrence rate, nevertheless, remains higher for proximal gastrectomy.

Key words:

proximal gastrectomy − oncological radicality − esophagogastric junction cancer − early gastric cancer

Zdroje

1. Ectors N, Driessen A, de Hertog G, et al. Is adenocarcinoma of the esophagogastric junction or cardia different from Barrett adenocarcinoma? Arch Pathol Lab Med 2005;128:183−5.

2. Available from: http://globocan.iarc.fr/Pages/_fact_sheets_cancer.aspx.

3. Availeble from: www.svod.cz.

4. Craanen ME, Deker W, Blok D, et al. Time trends in gastric cancer; changing patterns of type and location. Am J Gastroenterol 1992;87:572−9.

5. Powell J, McConkey CC. Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites. Brit J Cancer 1990;62:440−3.

6. Devesa SS, Blot WJ, Fraumeni JF jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer-Am Cancer Soc 1998;83:2049−53.

7. Bollschweiler E, Wolfgarten E, Gutschow C, et al. Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer-Am Cancer Soc 2001;92:549−55.

8. Sharma R, Samantaray S, Shukla NK, et al. Transcriptional gene expression profile of human esophageal squamous cell carcinoma. Genomics 2003;81:481−8.

9. Ishikawa S, Shimada S, Miyanari N, et al. Pattern of lymph node involvement in proximal gastric cancer. World J Surg 2009;33:1687−92.

10. Sasako M, Sano T, Yamamoto S, et al. Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial. Lancet Oncol 2006;7:644−51.

11. Kurokawa Y, Sasako M, Sano T, et al. Ten-year follow-up results of a randomized clinical trial comparing left thoracoabdominal and abdominal transhiatal approaches to total gastrectomy for adenocarcinoma of the esophagogastric junction or gastric cardia. Brit J Surg 2015;102:341−8.

12. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer 2017;20:1−19.

13. Gao F, Chen J, Wang T, et al. Incidence of microscopically positive proximal margin in adenocarcinoma of the gastroesophageal junction. PloS One 2014;9:e88010.

14. Szántó I, Vörös A, Nagy P, et al. Esophageal intramural metastasis from adenocarcinoma of the gastroesophageal junction. Endoscopy 2002;34:418−20.

15. Lam KY, Ma LT, Wong J. Measurement of extent of spread of oesophageal squamous carcinoma by serial sectioning. J Clin Pathol 1996;49:124−9.

16. Khoshnevis J, Moradi A, Azargashb E, et al. A study of contractility of proximal surgical margin in esophageal cancer. Iran J Cancer Prev 2013;6:26−27.

17. Mariette C, Castel B, Balon JM, et al. Extent of oesophageal resection for adenocarcinoma of the oesophagogastric junction. Eur J Surg Oncol 2003;29:588−93.

18. Ito H, Clancy TE, Osteen RT, et al. Adenocarcinoma of the gastric cardia: what is the optimal surgical approach? J Am Coll Surgeons 2004;199:880−6.

19. Barbour AP, Rizk NP, Gonen M, et al. Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcome. Ann Surg 2007;246:1−8.

20. Mine S, Sano T, Hiki N, et al. Proximal margin length with transhiatal gastrectomy for Siewert type II and III adenocarcinomas of the oesophagogastric junction. Brit J Surg 2013;100:1050−4.

21. Casson AG, Darnton SJ, Subramanian S, et al. What is the optimal distal resection margin for esophageal carcinoma? Ann Thorac Surg 2000;69:205−9.

22. Bonenkamp JJ, Songun I, Hermans J, et al. Randomised comparison of morbidity after D1 a D2 dissection for gastric cancer in 996 Dutch patients. Lancet 1995;345:745−8.

23. Songun I, Putter H, Kranenbarg EM, et al. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1/D2 trial. Lancet Oncol 2010;11:439−49.

24. Okines A, Vereheij M, Allum W, et al. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010;21 Suppl 5:v50−v54.

25. Waddell T, Verheij M, Allum W, et al. Gastric cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013;24 Suppl 6:vi57-vi63.

26. Ajani JA, Bentrem DJ, Besh S, et al. Gastric cancer, version 2.2013: featured updates to the NCCN guidelines. J Natl Compr Canc Ne 2013;11:531−46.

27. Okamura T, Tsujitani S, Korenaga D, et al. Lymphadenectomy for cure in patients with early gastric cancer and lymph node metastasis. Am J Surg 1988;155:476−80.

28. Kitamura K, Yamaguchi T, Nishida S, et al. The operative indications for proximal gastrectomy in patients with gastric cancer in the upper third of the stomach. Surg Today 1997;27:993−8.

29. Kitamura K, Nishida S, Yamamoto K, et al. Lymph node metastasis in gastric cancer in the upper third of the stomach: surgical treatment on the basis of the anatomical distribution of positive node. Hepatogastroenterology 1998;45:281−5.

30. Kaibara N, Nishimura O, Nishidoi K, et al. Proximal gastrectomy as the surgical procedure of choice for upper gastric carcinoma. J Surg Oncol 1987;36:110−2.

31. Kong SH, Kim JW, Lee HJ, et al. Reverse double-stapling end-to-end esophagogastrostomy in proximal gastrectomy. Digest Surg 2010;27:170−4.

32. Son MW, Kim YJ, Jeong GA, et al. Long-term outcomes of proximal gastrectomy for upper-third gastric cancer. J Gastric Cancer 2014;14:246−51.

33. Siewert JR, Feith M, Werner M, et al. Adenocarcinoma of the esophagogastric junction. Results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients. Ann Surg 2000;232:353−61.

34. Aikou T, Shimazu H. Difference in main lymphatic pathways from the lower esophagus and gastric cardia. Surg Today 1989;19:290−5.

35. Yonemura Y, Tsugawa K, Fonseca L, et al. Lymph node metastasis and surgical management of gastric cancer invading the esophagus. Hepato-Gastroenterology 1995;42:37−42.

36. Tachimori Y, Kato H, Watanabe H, et al. Difference between carcinoma of the lower esophagus and the cardia. World J Surg 1996;20:507−10.

37. Kobayashi T, Sugimura H, Kimura T. Total gastrectomy is not always neccessary for advanced gastric cancer of the cardia. Digest Surg 2002;19:15−21.

38. Sugoor P, Shah S, Dusane R, et al. Proximal gastrectomy versus total gastrectomy for proximal third gastric cancer: total gastrectomy is not always neccessary. Langenbeck Arch Surg 2016;401:687−97.

39. Maruyama K, Gunvén P, Okabayashi K, et al. Lymph node metastases of gastric cancer. General pattern in 1931 patients. Ann Surg 1989;210:596−602.

40. Sasako M, McCulloch P, Kinoshita T, et al. New method to evaluate the terapeutic value of lymph node dissection for gastric cancer. Brit J Surg 1995;82:346−51.

41. Yoshikawa T, Takeuchi H, Hasegawa S, et al. Theoretical therapeutic impact oflymph node dissection on adenocarcinoma and squamous cell carcinoma of the esophagogastric junction. Gastric Cancer 2016;19:143−9.

42. Sasako M, Sano T, Yamamoto S, et al. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. New Engl J Med 2008;359:453−62.

43. Hasegawa S, Yoshikawa T, Rino Y, et al. Priority of lymph node dissection for Siewert type II/III adenocarcinoma of the esophagogastric junction. Ann Surg Oncol 2013;20:4252−9.

44. Nunobe S, Ohyama S, Sonoo H, et al. Benefit of mediastinal and para-aortic lymph-node dissection for advanced gastric cancer with esophageal invasion. J Surg Oncol 2008;97:392−5.

45. Kurokawa Y, Hiki N, Yoshikawa T, et al. Mediastinal lymph node metastasis and recurrence in adenocarcinoma of the esophagogastric junction. Surgery 2015;157:551−5.

46. Hosokawa Y, Kinoshita T, Konishi M, et al. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan. Ann Surg Oncol 2012;19:677−83.

47. Pedrazzani C, de Manzoni G, Marrelli D, et al. Lymph node involvement in advanced gastroesophageal junction adenocarcinoma. J Thorac Cardiov Sur 2007;134:378−85.

48. Mine S, Sano T, Hiki N, et al. Proximal margin length with transhiatal gastrectomy for Siewert type II and III adenocarcinomas of the oesophagogastric junction. Brit J Surg 2013;100:1050−4.

49. de Manzoni G, Morgagni P, Roviello F, et al. Nodal abdominal spread in adenocarcinoma of the cardia. Results of a multicenter prospective study. Gastric Cancer 1998;1:146−51.

50. Haruta S, Shinohara H, Hosogi H, et al. Proximal gastrectomy with exclusion of No. 3b lesser curvature lymph node dissection could be indicated for patients with advanced upper-third gastric cancer. Gastric Cancer 2016. Available from: doi:10.1007/s10120-016-0624-2.

51. Huh YJ, Lee HJ, Oh SY, et al. Clinical outcome of modified laparoscopy-assisted proximal gastrectomy compared to conventional proximal gastrectomy or total gastrectomy for upper-third early gastric cancer with special references to postoperative reflux esophagitis. J Gastric Cancer 2015;15:191−200.

52. Jung DH, Ahn SH, Park DJ, et al. Proximal gastrectomy for gastric cancer. J Gastric Cancer 2015;15:77−86.

53. Ichikawa D, Komatsu S, Kubota T, et al. Long-term outcomes of patients who underwent limited proximal gastrectomy. Gastric Cancer 2014;17:141−5.

54. Nishigori T, Okabe H, Tsunoda S, et al. Superiority of laparoscopic proximal gastrectomy with hand-sewn esophagogastrostomy over total gastrectomy in improving postoperative body weight loss and quality of life. Surg Endosc. Published online 2017. Available from: doi:10.1007/s00464-016-5403-y.

55. Ahn SH, Lee JH, Park DJ, et al. Comparative study of clinical outcomes between laparoscopy-assisted proximal gastrectomy (LAPG) and laparoscopy-assisted total gastrectomy (LATG) for proximal gastric cancer. Gastric Cancer 2013;16:282−9.

56. Hayami M, Hiki N, Nunobe S, et al. Clinical outcomes and evaluation of laparoscopic proximal gastrectomy with double-flap technique for early gastric cancer in the upper third of the stomach. Ann Surg Oncol 2017;24:1635−42.

57. Kim JH, Park SS, Kim J, Boo YJ, et al. Surgical outcomes for gastric cancer in the upper third of the stomach. World J Surg 2006;30:1870−6.

58. Wen L, Chen XZ, Chen XL, et al. Total vs. proximal gastrectomy for proximal gastric cancer: a systematic review and meta-analysis. Hepatogastroenterology 2012. Available from: doi:10.5754/hge11834.

59. Pu YW, Gong W, Wu YY, et al. Proximal gastrectomy versus total gastrectomy for proximal gastric carcinoma. Saudi Med J 2013;34:1223−8.

60. Jeong O, Park YK. Clinicopathological features and surgical treatment of gastric cancer in South Korea: the results of 2009 nationwide survey on surgically treated gastric cancer patients. J Gastric Cancer 2011;11:69−77.

61. Vrba R, Aujeský R, Neoral Č. Výsledky limitované resekce karcinomu gastroezofageální junkce. Rozhl Chir 2012;91:368−72.

62. Vrba R, Aujeský R, Neoral Č, et al. Proximální gastrektomie u selektovaných pacientů s adenokarcinomem gastroezofageální junkce, bezprostřední a dlouhodobé výsledky operační terapie. Rozhl Chir 2016;95:439−43.